BVM Capital backs MicroBiome Therapeutics
MicroBiome Therapeutics has closed $1.3 million in bridge financing. Existing investor BVM Capital led the round with participation from MBT's other existing investors. Headquartered in Broomfield, Colorado, MicroBiome Therapeutics is a clinical stage biotechnology company that develops pharmaceutical and medical food products.
16 December 2013•2 mins read
